CTLA4 and HIV infectious disease: Sabbatino et al. have been reported a melanoma tumor response associated with a decreased viral replication and an increased number of CD4+ T cells in a patient with both HIV infection and metastatic melanoma during treatment with an antiretroviral therapy and an anti-CTLA-4 mAb [34].